KN
About
As an ATV venture partner, Ken focuses on the life sciences, including pharmaceuticals, bio-pharmaceuticals, in-vitro diagnostics and research products. Ken is currently a senior partner at L.E.K. Consulting LLP and head of its European Life Sciences Practice. Previously, he was senior vice president of Corporate Development for Applera Corporation; Vice President for the global consultancy Booz Allen & Hamilton, where he was head of its European Biopharmaceuticals Practice. Ken currently serves on the Board of Directors of Orchid Biosciences Inc. and Intercept Biopharmaceuticals Inc.
Position in the VCSift Database
- • 1,801 investors hold the Managing Director role in VCSift. Ken Noonan is one of them.
- • 1,940 investors are based in Singapore, Central Region, Singapore.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Singapore, Singapore
Contact Information
linkedin.com/in/••••••••
Find more investors like Ken
Search Investors